
Sign up to save your podcasts
Or


Will gene therapy companies produce healthy returns for investors? Ron Gross explains why he’s investing in gene therapy companies and shares his big question for the year ahead.
By The Motley Fool4.7
16041,604 ratings
Will gene therapy companies produce healthy returns for investors? Ron Gross explains why he’s investing in gene therapy companies and shares his big question for the year ahead.

3,218 Listeners

1,489 Listeners

807 Listeners

945 Listeners

523 Listeners

1,165 Listeners

2,182 Listeners

825 Listeners

1,422 Listeners

1,038 Listeners

9,719 Listeners

196 Listeners

829 Listeners

87 Listeners

591 Listeners

1,030 Listeners

53 Listeners